Potentiation of combined p19arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy

HIGHLIGHTS

  • who: Ruan F. V. Medrano from the Institut Universidade have published the paper: Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy, in the Journal: Scientific Reports Scientific Reports
  • what: With regard to the treatment order, the authors based the approach on the work of Fridlender and collaborators that showed that association of an adenoviral_vector encoding IFNβ with chemotherapy is more effective when gene transfer is applied ­first23. The experiments were carried out employing central composite rotational design (CCRD) where, for each cell line, a set of twelve . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?